CoChat
Sign Up
Cited by 844Congenital Heart Disease StudiesCongenital heart defects researchPrenatal Substance Exposure Effects

The DOI matches its Crossref record; 232 of the 232 references it cites were found in a registry or an index.

Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics

Jenkins, Kathy J., Correa, Adolfo, Feinstein, Jeffrey A., Botto, Lorenzo, Britt, Amy E., Daniels, Stephen R., Elixson, Marsha, Warnes, Carole A., Webb, Catherine L.·2007·Circulation
DOI 10.1161/circulationaha.106.183216
Open this paper in CoChat — free account

Abstract

Prevention of congenital cardiovascular defects has been hampered by a lack of information about modifiable risk factors for abnormalities in cardiac development. Over the past decade, there have been major breakthroughs in the understanding of inherited causes of congenital heart disease, including the identification of specific genetic abnormalities for some types of malformations. Although relatively less information has been available on noninherited modifiable factors that may have an adverse effect on the fetal heart, there is a growing body of epidemiological literature on this topic. This statement summarizes the currently available literature on potential fetal exposures that might alter risk for cardiovascular defects. Information is summarized for periconceptional multivitamin or folic acid intake, which may reduce the risk of cardiac disease in the fetus, and for additional types of potential exposures that may increase the risk, including maternal illnesses, maternal therapeutic and nontherapeutic drug exposures, environmental exposures, and paternal exposures. Information is highlighted regarding definitive risk factors such as maternal rubella; phenylketonuria; pregestational diabetes; exposure to thalidomide, vitamin A cogeners, or retinoids; and indomethacin tocolysis. Caveats regarding interpretation of possible exposure-outcome relationships from case-control studies are given because this type of study has provided most of the available information. Guidelines for prospective parents that could reduce the likelihood that their child will have a major cardiac malformation are given. Issues related to pregnancy monitoring are discussed. Knowledge gaps and future sources of new information on risk factors are described.

Overview

Integrity signals

Registry

Crossref · 10.1161/circulationaha.106.183216

Cites

232 of 232 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Items 201–232 of 232

Flagged first, then by citations

Research works printed but not linked: 7

  1. Gregg NM. Further observations on congenital defects in infants following maternal rubella. Trans Ophthalmol Soc Aust. 1944; 4: 119–131.
  2. 10.1161/circ.56.1.301070 · DOI
  3. Bracken MB. Drug use in pregnancy and congenital heart disease in offspring. N Engl J Med. 1986; 314: 1120.
  4. 10.1001/jama.1981.03320040015021 · DOI
  5. Netter JC, Choulot JJ, Dagues-Bie M. Oligohydramnios and persistent pulmonary arterial hypertension after use of ketoprofen during pregnancy. Sem Hop Paris. 1990; 66: 1953–1954.Abstract.
  6. 10.1097/00001648-199909000-00008 · DOI
  7. 10.1161/circ.47.2.359 · DOI

Cited by

Sorted by citations

See all 844

Related

See all

Metadata

Authors
Jenkins, K. J., Correa, A., Feinstein, J. A., Botto, L., Britt, A. E., Daniels, S. R., Elixson, M., Warnes, C. A., & Webb, C. L.
Affiliations
Boston Children's Hospital (US)
ORCID
Venue
Circulation
Publisher
Ovid Technologies (Wolters Kluwer Health)
Published
2007-06-12
Volume
115
Issue
23
Pages
2995-3014
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
DOI
10.1161/circulationaha.106.183216
OpenAlex
W2617245041
Cited by
818
References
232
Citations by year
2026: 21 · 2025: 26 · 2024: 50 · 2023: 42 · 2022: 52 · 2021: 42 · 2020: 50 · 2019: 48 · 2018: 52 · 2017: 38 · 2016: 43 · 2015: 61 · 2014: 55 · 2013: 52 · 2012: 48
FWCI
3.84
Type
journal article
Language
en
Open access
closed
Locations
  • Circulation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
congenital heart disease, modifiable risk factors, fetal heart development, periconceptional folic acid supplementation, maternal rubella infection, phenylketonuria, pregestational diabetes, thalidomide, retinoids, prenatal drug exposure, environmental exposure, paternal exposure, pregnancy monitoring
MeSH terms
Female, Fetal Diseases, Heart Defects, Congenital, Humans, Pregnancy, Risk Factors, Cardiovascular Abnormalities, Maternal Exposure, Dietary Supplements

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review